Fei Li

机构：Peking University, Sichuan University, West China Hospital of Sichuan University, Peking University Third Hospital · ORCID：0000-0002-2978-246X

发表论文 47 篇 · 总被引 565 次 · h-index 15

代表论文

• Glucagon Acting at the GLP-1 Receptor Contributes to β-Cell Regeneration Induced by Glucagon Receptor Antagonism in Diabetic Mice (2023 · Diabetes · 被引 48)
• Gut Microbiota−Tryptophan Metabolism−GLP-1 Axis Participates in β-Cell Regeneration Induced by Dapagliflozin (2024 · Diabetes · 被引 41)
• A glycolysis-related two-gene risk model that can effectively predict the prognosis of patients with rectal cancer (2022 · Human Genomics · 被引 39)
• Features of colorectal cancer in China stratified by anatomic sites: A hospital-based study conducted in university-affiliated hospitals from 2014 to 2018 (2021 · Chinese Journal of Cancer Research · 被引 23)
• High CFP score indicates poor prognosis and chemoradiotherapy response in LARC patients (2021 · Cancer Cell International · 被引 12)
• Loss of survival advantage for deficient mismatch repair in patients with advanced colorectal cancer may be caused by changes in prognostic value of CD8+T cell (2020 · World Journal of Surgical Oncology · 被引 12)